{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T14:04:49Z","timestamp":1775570689568,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,2]]},"DOI":"10.7759\/cureus.102865","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T07:46:37Z","timestamp":1770104797000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Recurrent Acute Pancreatitis After Gemcitabine + Nab-Paclitaxel and Modified FOLFIRINOX Therapy for Advanced Recurrent Pancreatic Cancer"],"prefix":"10.7759","author":[{"given":"Yusuke","family":"Inada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruna","family":"Sango","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriki","family":"Kasuga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Yukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiko","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.933","article-title":"Outcomes of 5000 pancreatectomies in Korean single referral center and literature reviews","volume":"29","author":"Byun Y","year":"2022","unstructured":"Byun Y, Choi YJ, Han Y, Kang JS, Kim H, Kwon W, Jang JY. Outcomes of 5000 pancreatectomies in Korean single referral center and literature reviews. J Hepatobiliary Pancreat Sci. 2022, 29:1327-35. 10.1002\/jhbp.933","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.11.023","article-title":"Drug-induced acute pancreatitis: an evidence-based review","volume":"5","author":"Badalov N","year":"2007","unstructured":"Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. 2007, 5:648-61; quiz 644. 10.1016\/j.cgh.2006.11.023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref3","article-title":"Drug-induced acute pancreatitis: a review","volume":"15","author":"Jones MR","year":"2015","unstructured":"Jones MR, Hall OM, Kaye AM, Kaye AD. Drug-induced acute pancreatitis: a review. Ochsner J. 2015, 15:45-51.","journal-title":"Ochsner J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi JD","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020, 395:2008-20. 10.1016\/S0140-6736(20)30974-0","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff DD","year":"2013","unstructured":"Von Hoff DD, Ervin T, Arena FP, et al.. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013, 369:1691-703. 10.1056\/NEJMoa1304369","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy T","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M, et al.. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011, 364:1817-25. 10.1056\/NEJMoa1011923","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e31829e2006","article-title":"Modified FOLFIRINOX regimen with improved safety and maintained efficacy in pancreatic adenocarcinoma","volume":"42","author":"Mahaseth H","year":"2013","unstructured":"Mahaseth H, Brutcher E, Kauh J, et al.. Modified FOLFIRINOX regimen with improved safety and maintained efficacy in pancreatic adenocarcinoma. Pancreas. 2013, 42:1311-5. 10.1097\/MPA.0b013e31829e2006","journal-title":"Pancreas"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-018-3577-9","article-title":"A phase II study of modified FOLFIRINOX for chemotherapy-na\u00efve patients with metastatic pancreatic cancer","volume":"81","author":"Ozaka M","year":"2018","unstructured":"Ozaka M, Ishii H, Sato T, et al.. A phase II study of modified FOLFIRINOX for chemotherapy-na\u00efve patients with metastatic pancreatic cancer. Cancer Chemother Pharmacol. 2018, 81:1017-23. 10.1007\/s00280-018-3577-9","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231883","article-title":"Drug induced pancreatitis: a systematic review of case reports to determine potential drug associations","volume":"15","author":"Wolfe D","year":"2020","unstructured":"Wolfe D, Kanji S, Yazdi F, et al.. Drug induced pancreatitis: a systematic review of case reports to determine potential drug associations. PLoS One. 2020, 15:e0231883. 10.1371\/journal.pone.0231883","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/BF01226272","article-title":"Granisetron-induced acute pancreatitis","volume":"122","author":"Rodier JM","year":"1996","unstructured":"Rodier JM, Pujade-Lauraine E, Batel-Copel L, Alexandre JH, Bernadou A. Granisetron-induced acute pancreatitis. J Cancer Res Clin Oncol. 1996, 122:132-3. 10.1007\/BF01226272","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/348889-a-case-of-recurrent-acute-pancreatitis-after-gemcitabine--nab-paclitaxel-and-modified-folfirinox-therapy-for-advanced-recurrent-pancreatic-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T07:46:37Z","timestamp":1770104797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/348889-a-case-of-recurrent-acute-pancreatitis-after-gemcitabine--nab-paclitaxel-and-modified-folfirinox-therapy-for-advanced-recurrent-pancreatic-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.102865","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,2]]}}}